Patent ID: 11873339
Assignee: PIERRE FABRE MEDICAMENT
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A  G | IPC A  C

Claim 13:
14. An in vitro method of detecting a C10orf54-mediated disease in a subject comprising:
(a) assaying the level of a human C10orf54 antigen in cells or a tissue sample of a subject using the antibody or antigen-binding fragment thereof of claim 1, the antibody being conjugated or recombinantly fused to a detectable agent; and
(b) comparing the level of the human C10orf54 antigen with a control level of the antigen, wherein an increase in the assayed human C10orf54 antigen level as compared to the control level of the human C10orf54 antigen is indicative of a C10orf54-mediated disease.